EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis

June Tome iD, Raseen Tariq, Leslie C Hassett, Sahil Khanna, Darrell S Pardi iD

Inflammatory Bowel Diseases · 03.07.2024 · 30 (7) · 1178-1188

DOI: 10.1093/ibd/izad178 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 17.08.2023. Verfasst von June Tome und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Budesonide, Colitis, Microscopic. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microscopic colitis (MC) is a common cause of chronic diarrhea. Randomized controlled trials (RCTs) have demonstrated the efficacy of budesonide treatment for MC. However, relapse is frequent after discontinuation of budesonide, and data on maintenance therapy are limited. We performed a systematic review and meta-analysis evaluating these outcomes in clinical trials and real-world settings.

Methods

A systematic search was performed on October 31, 2022, of Medline, Embase, Cochrane, and Scopus. Case series, case-control, cohort studies, and RCTs of adults with MC were included. Data were pooled using random effects models to calculate weighted pooled estimates and 95% confidence intervals. Heterogeneity was assessed using the I2 statistic.

Results

We included 35 studies (11 RCTs, 24 observational studies) with 1657 MC patients treated with budesonide induction and 146 for maintenance. The overall pooled clinical remission rate with budesonide treatment was similar between RCTs and observational studies. The pooled remission rate with budesonide maintenance therapy was 84% (95% CI, 0.60-1.00; I2 = 91%). After budesonide discontinuation, the pooled relapse rate was 53% (95% CI, 0.42-0.63; I2 = 76%). On maintenance therapy, no differences were noted in adverse events (eg, metabolic bone disease, hypertension, hyperglycemia, cataracts/glaucoma) in those on budesonide vs placebo or other noncorticosteroid medications for MC (P = .9).

Conclusions

Budesonide is an effective maintenance treatment for MC. There is a high risk of recurrence after budesonide discontinuation, but long-term use at the lowest effective dose appears to be relatively safe and have limited adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BudesonideColitis, MicroscopicHumansMaintenance ChemotherapyRecurrenceRemission InductionTreatment OutcomeRandomized Controlled Trials as TopicAnti-Inflammatory Agents

Stichwörter der Autor:innen

adverse effectsbudesonidecollagenous colitislymphocytic colitismicroscopic colitis

Substanzen

BudesonideAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: June Tome, Darrell S Pardi

Zitieren

APA

Tome, J., Tariq, R., Hassett, L. C., Khanna, S., & Pardi, D. S. (2024). Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases, 30(7), 1178-1188. https://doi.org/10.1093/ibd/izad178

Vancouver

Tome J, Tariq R, Hassett LC, Khanna S, Pardi DS. Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. 2024;30(7):1178-1188. doi:10.1093/ibd/izad178

BibTeX
@article{Tome2024,
  author = {Tome, June and Tariq, Raseen and Hassett, Leslie C and Khanna, Sahil and Pardi, Darrell S},
  title = {Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {7},
  pages = {1178--1188},
  doi = {10.1093/ibd/izad178}
}
Kostenlos starten →